Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon.
University Medical Centre, Utrecht, The Netherlands.
Int J Gynaecol Obstet. 2021 Feb;152(2):139-143. doi: 10.1002/ijgo.13456. Epub 2020 Dec 2.
Pregnant women and their fetuses are among the vulnerable populations that can be severely affected by communicable diseases. As such, some vaccines such as the influenza and the Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccines are strongly recommended in each pregnancy, with generally safe profiles. Other vaccines can be offered based on risk factors, and only when the benefits of receiving them outweigh the risks. Development of vaccines against group B streptococcus infection and respiratory syncytial virus infection are of great importance. In this paper, the recommendations for administration of each vaccine during pregnancy are discussed. The FIGO Committee for Safe Motherhood and Newborn Health Committee endorses the recommendations to vaccinate all pregnant women against influenza during the influenza season at any time during the pregnancy and against Tdap preferably between the 27th and 36th weeks of pregnancy in each pregnancy.
孕妇及其胎儿属于易受传染病严重影响的脆弱人群。因此，强烈建议在每次妊娠中接种某些疫苗，如流感疫苗和 Tdap（破伤风类毒素、无细胞白喉类毒素和百日咳）疫苗，这些疫苗通常具有良好的安全性。还可以根据危险因素提供其他疫苗，但只有在接种疫苗的益处超过风险时才可以接种。开发针对 B 群链球菌感染和呼吸道合胞病毒感染的疫苗非常重要。本文讨论了在怀孕期间接种每种疫苗的建议。FIGO 母婴安全和新生儿健康委员会支持在流感季节期间随时为所有孕妇接种流感疫苗，并在每次妊娠中最好在 27 至 36 孕周之间接种 Tdap 的建议。
